Nextbiotix, SAS logo

Nextbiotix, SAS

Nextbiotix is advancing multiple mono-strain Live Biotherapeutics product candidates using a specific natural-occurring strain of Faecalibacterium Prausnitzii into clinical studies across inflammatory bowel diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.exeliombio.com
Founded2018
Disease Focus
Development Stage
STOCK CODENon Listed
Address
67 rue des Godrans, 21000
Dijon
France
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/nextbiotics” connections=”true” suffix=””]